Acquired and congenital risk factors associated with cerebral venous sinus thrombosis.

Abstract:

:The mechanistic paradigm underlying venous thrombosis at atypical locations stems from the observation that most events occur as a result of pathology of the organ system drained by the involved venous segment. Cerebral venous sinus thrombosis stands apart as an exception to this general rule. Although brain and sinus pathology are well established causes, these combined variables account for approximately one third of cases. The marked female preponderance and strong association with gender specific risk factors including hormonal manipulation, pregnancy and the puerperium are particularly notable. Factor V Leiden and prothrombin G20210A mutations and hyperhomocysteinemia represent important risk factors particularly when combined with acquired variables. The association with oral contraception use and the prothrombin G20210A gene mutation may offer insights into the anatomic predilection for cerebral venous sinus involvement as compared to venous thrombosis of the lower extremities. The intent of this review is to summarize the corporate literature of both acquired and congenital risk factors associated with cerebral venous sinus thrombosis in order to assist clinicians in their search for underlying mechanisms and to risk stratify patients for anticoagulation treatment duration and risk of recurrent thrombosis.

journal_name

Thromb Res

journal_title

Thrombosis research

authors

McBane RD 2nd,Tafur A,Wysokinski WE

doi

10.1016/j.thromres.2010.04.015

subject

Has Abstract

pub_date

2010-08-01 00:00:00

pages

81-7

issue

2

eissn

0049-3848

issn

1879-2472

pii

S0049-3848(10)00253-7

journal_volume

126

pub_type

杂志文章,评审
  • Human platelets deficient in dense granules contain normal amounts of pp60c-src.

    abstract::We have determined that pp60c-src, a protein tyrosine kinase abundant in normal platelets, is present at comparable levels in platelets that are deficient in dense granules (Hermansky-Pudlak syndrome). Relative quantitation of pp60c-src was performed by immunoblot analysis after protein separation by sodium dodecyl su...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(92)90227-2

    authors: Sorisky A,Lages B,Weiss HJ,Rittenhouse SE

    更新日期:1992-01-01 00:00:00

  • Human platelet aggregation is not altered by Shiga toxins 1 or 2.

    abstract::The hemolytic uremic syndrome involves the presence of Shiga toxin producing strains of Escherichia coli and is associated with thrombocytopenia, platelet activation, and microthrombi formation. We have, therefore, investigated the ability of Shiga toxin isotypes 1 and 2 to cause or enhance platelet aggregation under ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(00)00191-2

    authors: Viisoreanu D,Polanowska-Grabowska R,Suttitanamongkol S,Obrig TG,Gear AR

    更新日期:2000-06-01 00:00:00

  • Validation of a novel tissue factor assay in experimental human endotoxemia.

    abstract:BACKGROUND:Nuclear factor kappa B (NF-kappa B) activation and tissue factor (TF) expression may contribute to lethality in sepsis. Inappropriate in vivo expression of TF is likely responsible for fibrin deposition in sepsis-associated disseminated intravascular coagulation (DIC). Clinical assessment of TF expression ha...

    journal_title:Thrombosis research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.thromres.2003.09.017

    authors: Marsik C,Quehenberger P,Mackman N,Osterud B,Luther T,Jilma B

    更新日期:2003-01-01 00:00:00

  • Outcome of patients with splanchnic venous thrombosis presenting without overt MPN: a role for the JAK2 V617F mutation re-evaluation.

    abstract:INTRODUCTION:Although investigation for JAK2 V617F mutation is recommended in patients presenting with splanchnic venous thrombosis (SVT), no specific clinical advice is given to SVT patients presenting without myeloproliferative neoplasms (MPN) and JAK2 V617F mutation. In MPN-free SVT patients, to investigate the clin...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2013.07.014

    authors: Colaizzo D,Amitrano L,Guardascione MA,Tiscia GL,D'Andrea G,Longo VA,Grandone E,Margaglione M

    更新日期:2013-08-01 00:00:00

  • Excessive expressions of T cell activation markers in pediatric immune thrombocytopenia.

    abstract:BACKGROUND:Immune thrombocytopenia (ITP) is an immune-mediated bleeding disorder in children. Activated T cells have been shown to play important roles in ITP. The aims of this study were to evaluate whether these T cell activation markers could be used as indicators to differentiate ITP patients from controls, and to ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2019.05.010

    authors: Chen Y,Zhou Y,Chen P,Zhang P,Jia M,Tang Y

    更新日期:2019-08-01 00:00:00

  • Thrombomodulin and ristocetincofactor in homocystinuria: a study in two siblings.

    abstract::Homocystinuria due to cystathionine-beta-synthase deficiency (CBS-def-HOCY) initially often presents with vascular disorders, e.g. thromboembolic events. The measurement of vascular endothelial markers in plasma could help to assess endothelial damage. We determined von Willebrand factor (measured as Ristocetincofacto...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(95)90867-f

    authors: Schienle HW,Seitz R,Nawroth P,Rohner I,Lerch L,Krumpholz B,Krauss G,Fowler B,Baumgartner R,Willenbockel U

    更新日期:1995-01-01 00:00:00

  • Feasibility of the Von Willebrand disease PREVENT trial.

    abstract:BACKGROUND:Despite treatment, women with von Willebrand disease (VWD) have lower von Willebrand factor (VWF) levels and greater blood loss at delivery than controls. Current weight-based dosing does not account for the ~1.5-fold increase in blood volume in pregnancy. METHODS:To evaluate the feasibility of a trial to p...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2017.05.022

    authors: Ragni MV,Machin N,James AH,Seaman CD,Malec LM,Kessler CM,Konkle BA,Kouides PA,Neff AT,Philipp CS,Brooks MM

    更新日期:2017-08-01 00:00:00

  • Polyphenols downregulate PAI-1 gene expression in cultured human coronary artery endothelial cells: molecular contributor to cardiovascular protection.

    abstract::Epidemiologic data have indicated that the intake of polyphenols is inversely associated with mortality from cardiovascular disease. Mitogen-activated protein kinases (MAPKs) are ubiquitous signaling proteins that have been associated with gene regulation. This study determined whether polyphenols (catechin and querce...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2007.02.001

    authors: Pasten C,Olave NC,Zhou L,Tabengwa EM,Wolkowicz PE,Grenett HE

    更新日期:2007-01-01 00:00:00

  • Safety of virus inactivated antithrombin III concentrate antithrombin III immuno (AT III).

    abstract::In a prospective clinical trial the risk of infection after application of virus inactivated antithrombin III concentrate ANTITHROMBIN III IMMUNO (AT III) was investigated in patients undergoing cardiovascular surgery. The study was conducted according to the recommendations of the International Committee on Thrombosi...

    journal_title:Thrombosis research

    pub_type: 临床试验,杂志文章

    doi:10.1016/0049-3848(92)90107-l

    authors: Preiss DU,Abdullah D,Eberspächer B,Wilhelm K

    更新日期:1992-03-15 00:00:00

  • Dilute prothrombin time-based lupus ratio test. Integrated LA testing with recombinant tissue thromboplastin.

    abstract::The lupus ratio (LR) test is a normalized ratio of the clotting times obtained with low and high phospholipid (PL) concentrations, where the test plasma is mixed 1:1 with normal pooled plasma (NP). As an integrated, automated, and computer-assisted assay, this principle has been applied to the dilute activated partial...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(01)00420-0

    authors: Liestøl S,Jacobsen EM,Wisløff F

    更新日期:2002-01-15 00:00:00

  • Screening for anemia in patients on warfarin facilitates diagnosis of gastrointestinal malignancies and pre-malignant lesions.

    abstract:INTRODUCTION:The prevalence and etiology of occult bleeding among patients on warfarin who are screened systematically for new anemia is largely unknown. We aimed to estimate the usefulness of following hemoglobin and mean red cell volume (MCV) with INR in order to screen for developing anemia as an indicator of occult...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2012.05.005

    authors: Johannsdottir GA,Onundarson PT,Gudmundsdottir BR,Bjornsson ES

    更新日期:2012-09-01 00:00:00

  • Inhibitory effect of fibronectin on the fibrin formation.

    abstract::125I-fibronectin is incorporated into fibrin when blood plasma is clotted with thrombin. This process is dependent upon fibronectin concentration, temperature, and the presence of calcium ions. Fibronectin appears to be a very strong inhibitor of fibrin formation and influences both the thrombin clotting time and fibr...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(82)90308-5

    authors: Niewiarowska J,Cierniewski CS

    更新日期:1982-09-01 00:00:00

  • Hypermucoviscous Klebsiella pneumoniae infections induce platelet aggregation and apoptosis and inhibit maturation of megakaryocytes.

    abstract:INTRODUCTION:Different Klebsiella pneumoniae strains carry different virulence factors and antibiotic resistance and may cause thrombocytopenia. This study aimed to investigate the effects of different infections caused by K. pneumoniae on platelets. METHODS:Two hypermucoviscous K. pneumoniae strains and two classic s...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2018.09.053

    authors: Wang Z,Ren J,Liu Q,Li J,Wu X,Wang W,Wu J,Wang G,Li J

    更新日期:2018-11-01 00:00:00

  • A simple screening assay for certain fibrinolysis parameters (FIPA).

    abstract::Hemostasis, the system of generation and degradation of thrombi, consists of coagulation and fibrinolysis. Whereas global assays to study coagulation have existed for many years, there has been no simple, rapid, and economic routine test for the plasmatic fibrinolysis parameters plasminogen activator inhibitor-1, alph...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(99)00165-6

    authors: Stief TW,Hinz F,Kurz J,Doss MO,Kretschmer V

    更新日期:2000-02-15 00:00:00

  • The effect of the carboxy-terminal lysine of urokinase on the catalysis of plasminogen activation.

    abstract::When single-chain pro-UK is activated by plasmin or kallikrein, the Lys158-Ile159 bond is cleaved, leaving a C-terminal lysine on the A-chain (Lys-UK). Two-chain, high molecular weight urokinase (UK) purified from urine, however, has been shown to contain a phenylalanine residue as the C-terminal of the A-chain (Phe-U...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(91)90206-c

    authors: Lenich C,Pannell R,Gurewich V

    更新日期:1991-10-01 00:00:00

  • Residual perfusion defects in patients with pulmonary embolism are related to impaired fibrinolytic capacity.

    abstract:BACKGROUND:Few studies investigated the relationship between fibrinolysis abnormalities and residual pulmonary perfusion defects after acute pulmonary embolism (PE). OBJECTIVE:To assess the fibrinolytic profile in patients with prior PE in relation to the extent of scintigraphically detectable residual perfusion abnor...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2014.07.013

    authors: Lami D,Cellai AP,Antonucci E,Fiorillo C,Becatti M,Grifoni E,Cenci C,Marcucci R,Mannini L,Miniati M,Abbate R,Prisco D

    更新日期:2014-09-01 00:00:00

  • Effect of fucoidan during activation of human plasminogen.

    abstract::Fucoidan [sulfated poly (L-fucopyranose)] was compared with 6-aminohexanoic acid (6-AH) or CNBr-cleaved fibrinogen (CNBr-Fbg) alone or in combination in enhancing the activation of glutamic plasminogen (Glu-Plg) or lysine plasminogen (Lys-Plg) by two-chain tissue plasminogen activator (t-PA) or LMwt-urokinase or by st...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(95)00111-4

    authors: Doctor VM,Hill C,Jackson GJ

    更新日期:1995-08-01 00:00:00

  • A retrospective cohort study of venous thromboembolism(VTE) in 1035 Japanese myeloma patients treated with thalidomide; lower incidence without statistically significant association between specific risk factors and development of VTE and effects of throm

    abstract:BACKGROUND:Rate of thalidomide-related VTE and risk factors in Japanese myeloma patients are not clear and effects of thromboprophylaxis remain controvertial. PATIENTS AND METHODS:We retrospectively analyzed a cohort data of registered Japanese myeloma patients treated with thalidomide-based regimens between 2009 and ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2012.11.014

    authors: Kato A,Takano H,Ichikawa A,Koshino M,Igarashi A,Hattori K,Nagata K

    更新日期:2013-02-01 00:00:00

  • Comparison of microvesicle tissue factor activity in non-cancer severely ill patients and cancer patients.

    abstract:INTRODUCTION:Increased levels of circulating tissue factor (TF)-positive microvesicles (MVs) may increase the risk of thrombosis. Indeed, TF-positive MVs are detected in plasma of patients with various types of diseases. In this study, we measured levels of MV TF activity in non-cancer severely ill patients and cancer ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2018.03.001

    authors: Hisada Y,Thålin C,Lundström S,Wallén H,Mackman N

    更新日期:2018-05-01 00:00:00

  • Protective activity of defibrotide against lethal acute myocardial ischemia in the cat.

    abstract::Defibrotide (D) is a natural polydeoxyribonucleotide from mammalian lungs with profibrinolytic and antithrombotic activities. D also has PGI2-stimulating and tissue plasminogen activator (TPA)-releasing activities, but has no anticoagulant properties. The protective effects of D were demonstrated very recently in a mo...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(86)90265-3

    authors: Niada R,Porta R,Pescador R,Mantovani M,Prino G

    更新日期:1986-05-01 00:00:00

  • The clock gene Per2 is required for normal platelet formation and function.

    abstract:INTRODUCTION:Apoptotic cell death is a highly regulated genetic program, which has been observed in mature megakaryocytes fragmenting into platelets. The clock gene Per2, a key component of core clock oscillator, was involved in affecting both cell cycle control and apoptosis. Thus, loss of Per2 function may be conside...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2010.11.025

    authors: Zhao Y,Zhang Y,Wang S,Hua Z,Zhang J

    更新日期:2011-02-01 00:00:00

  • Effectiveness of alternative treatments for reducing potential viral contaminants from plasma-derived products.

    abstract::An issue of great importance and continuing concern with regard to all products derived from human plasma is their safety from potential contaminants in the source material from which they are purified. Since viral contaminants are a major safety consideration with these products, a number of different methods, includ...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/s0049-3848(02)00044-0

    authors: Chandra S,Groener A,Feldman F

    更新日期:2002-03-01 00:00:00

  • The alkenylacyl class of ethanolamine phospholipid represents a major form of eicosapentaenoic acid (EPA)-containing phospholipid in the platelets of human subjects consuming a fish oil concentrate.

    abstract::A quantitative assessment was made of the distribution of arachidonic acid (AA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) among the individual sub-classes (diacyl, alkylacyl, alkenylacyl) of the various platelet phospholipids of human subjects consuming a fish oil concen...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(88)90181-8

    authors: Holub BJ,Celi B,Skeaff CM

    更新日期:1988-04-01 00:00:00

  • A direct, plasmin-independent assay for plasminogen activator.

    abstract::A direct assay for plasminogen activator (PA) was developed. It employed polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate and beta-mercaptoethanol to monitor PA-mediated conversion of single chain, 125I-plasminogen to two chain plasmin. By incorporating Triton X-100, albumin and trasylol in...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(84)90008-2

    authors: Mussoni L,Lawrence D,Loskutoff DJ

    更新日期:1984-05-01 00:00:00

  • Fondaparinux versus nadroparin for thromboprophylaxis following minimally invasive esophagectomy: A randomized controlled trial.

    abstract:BACKGROUND:The methodology of thromboprophylaxis post minimally invasive esophagectomy (MIE) is unclear. Thus, we compared the efficacy and safety of fondaparinux and nadroparin on the prophylaxis of venous thromboembolism (VTE) after MIE. MATERIALS AND METHODS:We conducted a randomized, double-blind, treatment-contro...

    journal_title:Thrombosis research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.thromres.2018.04.001

    authors: Song J,Xuan L,Wu W,Shen Y,Tan L,Zhong M

    更新日期:2018-06-01 00:00:00

  • Treatment of patients with acute deep vein thrombosis and/or pulmonary embolism: efficacy and safety of non-VKA oral anticoagulants in selected populations.

    abstract::Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), presents a large clinical burden. Prompt, effective and sustained anticoagulation is vital because of the risk of recurrent events, including life-threatening PE, and complications such as post-thrombotic syndrome and chro...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/j.thromres.2014.05.013

    authors: Prandoni P

    更新日期:2014-08-01 00:00:00

  • Catalytic and fibrinolytic properties of recombinant urokinase plasminogen activator from E. coli, mammalian, and yeast cells.

    abstract::The enzymatic and fibrinolytic properties of glycosylated and nonglycosylated recombinant human pro-urokinase (pro-UK) produced in yeast Pichia pastoris were characterized and compared with those of Escherichia coli and mammalian cell-derived pro-UK. Among the five different forms of pro-UK, the yeast glycosylated pro...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(00)00349-2

    authors: Wang P,Zhang J,Sun Z,Chen Y,Gurewich V,Liu JN

    更新日期:2000-12-01 00:00:00

  • Cilostazol inhibits the expression of activation-dependent membrane surface glycoprotein on the surface of platelets stimulated in vitro.

    abstract::Cilostazol is a newly developed antiplatelet drug that has been widely applied for clinical use. Its antiplatelet action appears to be mainly related to inhibition of intracellular phosphodiesterase activity. Our study was designed to investigate inhibitory effects of cilostazol on the expression of activation-depende...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(98)00172-8

    authors: Inoue T,Sohma R,Morooka S

    更新日期:1999-02-01 00:00:00

  • A novel anti-platelet peptide (Z4A5) potential for glycoprotein IIb/IIIa inhibits platelet aggregation.

    abstract:INTRODUCTION:Z4A5 is a novel peptide that inhibits platelet aggregation and formation of platelet thrombi, but the mechanism of its anti-platelet effects remains unknown. This study explores the anti-platelet effect and mechanism of Z4A5. METHODS:We investigated the anti-platelet activity of Z4A5 on platelet aggregati...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2012.02.047

    authors: Li YX,Sun Q,Zhang H,Ren ST,Liao YR,Wang Y,Shen XL,Wang B

    更新日期:2012-05-01 00:00:00

  • The inhibition of thromboplastin by apolipoprotein-B and the effect of various associated lipids.

    abstract::Human apolipoprotein B was purified by barium sulphate adsorption, subsequent delipidation and gel filtration. The protein was then reconstituted in soya bean lecithin and its inhibitory effect towards thromboplastin was assayed by incubation with rabbit brain thromboplastin. The use of an antibody against human apoli...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(92)90033-7

    authors: Ettelaie C,Howell RM

    更新日期:1992-10-15 00:00:00